121 related articles for article (PubMed ID: 19016453)
1. Enhancement of bone formation in hydroxyapatite implants by rhBMP-2 coating.
Schnettler R; Knöss PD; Heiss C; Stahl JP; Meyer C; Kilian O; Wenisch S; Alt V
J Biomed Mater Res B Appl Biomater; 2009 Jul; 90(1):75-81. PubMed ID: 19016453
[TBL] [Abstract][Full Text] [Related]
2. Effect of bone morphogenetic protein-2/hydroxyapatite on ankle fusion with bone defect in a rabbit model: a pilot study.
Dang LHN; Lee KB
J Orthop Surg Res; 2020 Aug; 15(1):366. PubMed ID: 32859231
[TBL] [Abstract][Full Text] [Related]
3. Glycerol-l-lactide coating polymer leads to delay in bone ingrowth in hydroxyapatite implants.
Schnettler R; Pfefferle HJ; Kilian O; Heiss C; Kreuter J; Lommel D; Pavlidis T; Stahl JP; Meyer C; Wenisch S; Alt V
J Control Release; 2005 Aug; 106(1-2):154-61. PubMed ID: 15936110
[TBL] [Abstract][Full Text] [Related]
4. Bone ingrowth in bFGF-coated hydroxyapatite ceramic implants.
Schnettler R; Alt V; Dingeldein E; Pfefferle HJ; Kilian O; Meyer C; Heiss C; Wenisch S
Biomaterials; 2003 Nov; 24(25):4603-8. PubMed ID: 12951003
[TBL] [Abstract][Full Text] [Related]
5. Controlled-release of bone morphogenetic protein-2 from a microsphere coating applied to acid-etched Ti6AL4V implants increases biological bone growth in vivo.
Fu Y; Zhang Q; Sun Y; Liao W; Bai X; Zhang L; Du L; Jin Y; Wang Q; Li Z; Wang Y
J Orthop Res; 2014 Jun; 32(6):744-51. PubMed ID: 24536004
[TBL] [Abstract][Full Text] [Related]
6. Increased osseointegration effect of bone morphogenetic protein 2 on dental implants: an in vivo study.
Yoo D; Tovar N; Jimbo R; Marin C; Anchieta RB; Machado LS; Montclare J; Guastaldi FP; Janal MN; Coelho PG
J Biomed Mater Res A; 2014 Jun; 102(6):1921-7. PubMed ID: 23853058
[TBL] [Abstract][Full Text] [Related]
7. The effect of recombinant human bone morphogenetic protein-2 on the integration of porous hydroxyapatite implants with bone.
Koempel JA; Patt BS; O'Grady K; Wozney J; Toriumi DM
J Biomed Mater Res; 1998 Sep; 41(3):359-63. PubMed ID: 9659603
[TBL] [Abstract][Full Text] [Related]
8. Guided tissue engineering for healing of cancellous and cortical bone using a combination of biomaterial based scaffolding and local bone active molecule delivery.
Raina DB; Qayoom I; Larsson D; Zheng MH; Kumar A; Isaksson H; Lidgren L; Tägil M
Biomaterials; 2019 Jan; 188():38-49. PubMed ID: 30321863
[TBL] [Abstract][Full Text] [Related]
9. Growth of new bone guided by implants in a murine calvarial model.
Freilich M; M Patel C; Wei M; Shafer D; Schleier P; Hortschansky P; Kompali R; Kuhn L
Bone; 2008 Oct; 43(4):781-8. PubMed ID: 18589010
[TBL] [Abstract][Full Text] [Related]
10. Alveolar ridge augmentation using implants coated with recombinant human bone morphogenetic protein-2: histologic observations.
Wikesjö UM; Qahash M; Polimeni G; Susin C; Shanaman RH; Rohrer MD; Wozney JM; Hall J
J Clin Periodontol; 2008 Nov; 35(11):1001-10. PubMed ID: 18976397
[TBL] [Abstract][Full Text] [Related]
11. The effects of recombinant human bone morphogenetic protein-2-loaded tricalcium phosphate microsphere-hydrogel composite on the osseointegration of dental implants in minipigs.
Lee JH; Ryu MY; Baek HR; Lee HK; Seo JH; Lee KM; Lee AY; Zheng GB; Chang BS; Lee CK
Artif Organs; 2014 Feb; 38(2):149-58. PubMed ID: 24571511
[TBL] [Abstract][Full Text] [Related]
12. Hydroxyapatite ceramic coating for bone implant fixation. Mechanical and histological studies in dogs.
Søballe K
Acta Orthop Scand Suppl; 1993; 255():1-58. PubMed ID: 8237337
[TBL] [Abstract][Full Text] [Related]
13. Effect of glycerol-L-lactide coating polymer on bone ingrowth of bFGF-coated hydroxyapatite implants.
Alt V; Pfefferle HJ; Kreuter J; Stahl JP; Pavlidis T; Meyer C; Mockwitz J; Wenisch S; Schnettler R
J Control Release; 2004 Sep; 99(1):103-11. PubMed ID: 15342184
[TBL] [Abstract][Full Text] [Related]
14. Hydroxyapatite and collagen combination-coated dental implants display better bone formation in the peri-implant area than the same combination plus bone morphogenetic protein-2-coated implants, hydroxyapatite only coated implants, and uncoated implants.
Lee SW; Hahn BD; Kang TY; Lee MJ; Choi JY; Kim MK; Kim SG
J Oral Maxillofac Surg; 2014 Jan; 72(1):53-60. PubMed ID: 24331565
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of implants coated with rhBMP-2 using two different coating strategies: a critical-size supraalveolar peri-implant defect study in dogs.
Lee J; Decker JF; Polimeni G; Cortella CA; Rohrer MD; Wozney JM; Hall J; Susin C; Wikesjö UM
J Clin Periodontol; 2010 Jun; 37(6):582-90. PubMed ID: 20345393
[TBL] [Abstract][Full Text] [Related]
16. Effect of recombinant human bone morphogenetic protein-2 on bone regeneration in large defects of the growing canine skull after dura mater replacement with a dura mater substitute.
He D; Genecov DG; Herbert M; Barcelo R; Elsalanty ME; Weprin BE; Opperman LA
J Neurosurg; 2010 Feb; 112(2):319-28. PubMed ID: 19267528
[TBL] [Abstract][Full Text] [Related]
17. Posterolateral lumbar fusion using Escherichia coli-derived rhBMP-2/hydroxyapatite in the mini pig.
Kong CB; Lee JH; Baek HR; Lee CK; Chang BS
Spine J; 2014 Dec; 14(12):2959-67. PubMed ID: 24937799
[TBL] [Abstract][Full Text] [Related]
18. Use of a perforated scaffold-retaining abutment to achieve vertical bone regeneration around dental implants in the minipig.
Catros S; Wen B; Schleier P; Shafer D; Dard M; Obrecht M; Freilich M; Kuhn L
Int J Oral Maxillofac Implants; 2013; 28(2):432-43. PubMed ID: 23527345
[TBL] [Abstract][Full Text] [Related]
19. Bone formation at porous titanium implants coated with multiple layers of recombinant human bone morphogenetic protein-2 cDNA plasmid in the posterior mandible in dogs.
He FM; Shan HQ; Shen JW; Jiang QH
Int J Oral Maxillofac Implants; 2013; 28(6):1648-54. PubMed ID: 24278934
[TBL] [Abstract][Full Text] [Related]
20. Development of a hydroxyapatite/collagen nanocomposite as a medical device.
Itoh S; Kikuchi M; Koyama Y; Takakuda K; Shinomiya K; Tanaka J
Cell Transplant; 2004; 13(4):451-61. PubMed ID: 15468687
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
